LONDON BROKER RATINGS: UBS cuts Standard Chartered; Shore ups HSBC
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 1,961.00p on 27-07-2026 at 16:45:08 |
|---|---|
| Change | 41.50p 2.16% |
| Buy | 1,973.00p |
| Sell | 1,972.50p |
| Last Trade: | Unknown 515.00 at 1,961.00p |
| Day's Volume: | 13,331,274 |
| Last Close: | 1,961.00p |
| Open: | 1,940.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,932.00p - 1,980.00p |
| 52wk Range: | 1,361.00p - 2,282.00p |
| Market Capitalisation: | £78.55b |
| VWAP: | 1,949.40897p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 515 | 1,961.00p | OTC Trade |
16:56:16 - 27-Jul-26 |
| Unknown* | 432 | 1,961.00p | OTC Trade |
16:56:16 - 27-Jul-26 |
| Unknown* | 4,586 | 1,961.00p | OTC Trade |
16:56:13 - 27-Jul-26 |
| Sell* | 308 | 1,961.00p | SI Trade Suspected SELL Trade |
16:49:09 - 27-Jul-26 |
| Sell* | 203 | 1,961.00p | SI Trade Suspected SELL Trade |
16:49:09 - 27-Jul-26 |
| Sell* | 1,375 | 1,954.205p | SI Trade Suspected SELL Trade |
16:47:05 - 27-Jul-26 |
| Sell* | 129,190 | 1,959.768p | SI Trade Suspected SELL Trade |
16:41:46 - 27-Jul-26 |
| Sell* | 305 | 1,961.00p | SI Trade |
16:35:23 - 27-Jul-26 |
| Sell* | 13 | 1,961.00p | SI Trade |
16:35:23 - 27-Jul-26 |
| Sell* | 543 | 1,961.00p | SI Trade |
16:35:23 - 27-Jul-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
| 22nd Jul 2026 5:22 pm | RNS | Jideytro approved in US for certain lung cancers |
| 20th Jul 2026 7:00 am | RNS | Bexsero 1-dose booster EMA file acceptance |
| 17th Jul 2026 12:00 pm | RNS | Audit tender conclusion |
| 17th Jul 2026 9:30 am | RNS | Camlipixant phase III results update |
| 16th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jul 2026 1:38 pm | RNS | GSK completes acquisition of Nuvalent, Inc |
| 14th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |